ResearcherGuiyang Medical UniversityActive in the last 2 years

Shi Zuo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8595-5062; OpenAlex author ID A5024882129. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 4

AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cancer. Co-author DOI 10.1038/s41419-025-08263-y ↗
Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA1522. Co-author DOI 10.1111/ajco.14048 ↗
NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1. Last author DOI 10.1016/j.bcp.2023.115811 ↗
Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fmolb.2021.745409 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

She Tian · 1 shared paper, 2024 · strength 0.26
- Paper Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing … DOI 10.1111/ajco.14048 ↗
Yuting Guo · 1 shared paper, 2024 · strength 0.26
- Paper Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing … DOI 10.1111/ajco.14048 ↗
Chao Yu · 1 shared paper, 2024 · strength 0.26
- Paper Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing … DOI 10.1111/ajco.14048 ↗
Cheng-Yi Sun · 1 shared paper, 2024 · strength 0.26
- Paper Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing … DOI 10.1111/ajco.14048 ↗
Ziying Jian · 1 shared paper, 2025 · strength 0.22
- Paper AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cance… DOI 10.1038/s41419-025-08263-y ↗
Zhiheng Zhang · 1 shared paper, 2025 · strength 0.22
- Paper AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cance… DOI 10.1038/s41419-025-08263-y ↗
Benli Xiao · 1 shared paper, 2023 · strength 0.18
- Paper NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1. DOI 10.1016/j.bcp.2023.115811 ↗
Jingjing Xiao · 1 shared paper, 2021 · strength 0.13
- Paper Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma. DOI 10.3389/fmolb.2021.745409 ↗
Tao Liu · 1 shared paper, 2021 · strength 0.13
- Paper Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma. DOI 10.3389/fmolb.2021.745409 ↗
Huajian Gu · 1 shared paper, 2021 · strength 0.13
- Paper Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma. DOI 10.3389/fmolb.2021.745409 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.